Long-term partnership to be established between Resilience and AstraZeneca for the biomanufacturing of established and emerging modalities.
West Chester, Ohio site will become Resilience’s global center of excellence for commercial drug product manufacturing and will also produce select AstraZeneca medicines over a multi-year supply agreement.
